Going back to the Feb 28, 2017 PR: (Please bear with me

New Post Public Reply Private Reply Replies (1) Message Board
grubstake
498
Going back to the Feb 28, 2017 PR: (Please bear with me here.)

COATES INTERNATIONAL, LTD. HAS AN AGREEMENT IN PLACE WITH SECURE SUPPLIES USA LLC AND SECURE SUPPLIES MEXICO LLC – INITIAL ORDERS WILL BE FOR A PROJECT IN NEW JERSEY THAT WILL REQUIRE 35, 1MW CSRV HYDROGEN POWERED INDUSTRIAL GEN SETS AND A PROJECT IN MEXICO THAT WILL REQUIRE 40, 1 MW CSRV HYDROGEN POWERED INDUSTRIAL GEN SETS -ESTIMATED VALUE OF THESE PROJECTS IS $35,000,000 IN NEW JERSEY AND $40,000,000 IN MEXICO FOR A TOTAL VALUE TO COATES OF $75,000,000

"Wall Township, NJ – (Globe Newswire – February 28, 2017) For Immediate Release: Coates International, Ltd. (OTC PINK: COTE) (the “Company”) has previously entered into a sublicense agreement with Secure Supplies USA LLC and Secure Supplies Mexico LLC (together “Secure Supplies”). In addition to a $1 million licensing fee to be paid upfront, the Company will also fulfill orders to manufacture and deliver 35 1MW CSRV Hydrogen Powered Industrial Electric Power Generator Sets (“Hydrogen Gen Sets”) for the project in New Jersey and 40 1MW CSRV Hydrogen Gen Sets for Mexico. Secure Supplies has informed the Company that it anticipates receiving funding from its customers to enable it to remit payments to us for the sublicense fee and for 50% of the order value to be paid with orders it intends to place, beginning in March 2017."

Does this not indicate that an order has been received from SS for a 1 MW gen set and that gen set is the one that was already being shipped from Cummins to Coates...? “An initial 1MW V12 Industrial engine from Cummins is already en route to the Coates facility in New Jersey for development of the Hydrogen Gen Sets for this larger engine specification;..."

And that George is in fact now converting this V12 engine with CSRV technology that will accommodate H2 fuel. Then a 50% deposit must have already been paid to Coates for that order or he would not have ordered the V12 from Cummins. To my understanding, this means that Coates has already started limited production of a V12 gen set to be shipped to SS. Would SS not have paid the $1 million license fee by the time shipment takes place?

Just trying to fit the pieces together. If my reasoning is correct, I believe we can expect another PR within the next two weeks or whenever the shipment takes place.



Coates International (COTE) Stock Research Links

COTE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nvidia's Major $500 Million Investment in Wayve for AI Expansion

Updated Category News Views 206

Nvidia Invests $500 Million in Wayve Nvidia, known for its advanced AI technologies, is in discussions to invest a substantial $500 million into the U.K.-based autonomous driving startup Wayve. This move marks a significant step for Nvidia as it seeks to deepen its involvement in the rapidly evolving artificial intelligence sector. Strategic Importance of the Investment...

Continue Reading
Vortex Companies Enhances Leadership with Key Promotions

Updated Category News Views 164

Elevating Leadership at Vortex Companies Vortex Companies, known for its rapid growth in the trenchless infrastructure rehabilitation sector, has recently made significant leadership changes with the promotions of Jonathan Thomas and Connor Mathis. Thomas steps into the role of Senior Regional Vice President for the Coastal Region, while Mathis ascends to Regional Vice...

Continue Reading
Scilex Holding Company Receives FDA Acknowledgment for ELYXYB

Updated Category News Views 118

Scilex Holding Company’s FDA Milestone with ELYXYB Scilex Holding Company, based in Palo Alto, California, has gained significant recognition with the U.S. FDA's acknowledgment of their Supplemental New Drug Application (SNDA) for ELYXYB. This marks a substantial step forward for the company, which is dedicated to creating and advancing non-opioid pain management...

Continue Reading
Bio-Techne Expands AI-Driven Protein Portfolio

Updated Category News Views 8

Advanced Proteins in the Spotlight Bio-Techne’s latest move is creating some serious buzz in the life sciences scene. They're not just talking the talk but walking the walk by expanding their R&D Systems AI-Engineered Designer Protein portfolio. What's the big news? They've engineered heat-stable and hyperactive proteins that promise to shake up fibroblast growth factor...

Continue Reading
PolyPid's D-PLEX100 Trial Results Revolutionize Infection Prevention

Updated Category News Views 146

Groundbreaking Advances in Surgical Infection Prevention PolyPid Ltd. has made headlines recently, unveiling remarkable topline results from their pivotal SHIELD II Phase 3 trial. This innovative study showcased D-PLEX100, a major breakthrough in preventing surgical site infections (SSIs), showing statistically significant reductions in both primary and secondary...

Continue Reading